Tekla Life Sciences Inves... (HQL)
NYSE: HQL
· Real-Time Price · USD
16.58
0.13 (0.79%)
At close: Oct 16, 2025, 3:59 PM
16.78
1.21%
After-hours: Oct 16, 2025, 06:52 PM EDT
Tekla Life Sciences Investors Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 |
Revenue | 18.2M | 1.91M | 2.07M | 29.56M | 1.93M | 21.69M | 10.17M | 15.98M | 29.03M |
Cost of Revenue | 2.53M | 2.83M | 2.53M | 2.59M | n/a | 2.64M | 2.91M | 3.1M | 2.97M |
Gross Profit | n/a | 1.91M | 2.07M | 26.97M | 1.93M | 19.05M | 7.27M | 12.87M | 26.06M |
Operating Income | -47.23M | -1.27M | -653.34K | -11.45M | -940.75K | -28.31M | -76.3M | 32.97M | 31.56M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -47.23M | 35.04M | 50.26M | -11.45M | 33.8M | -28.31M | -76.3M | 32.98M | 31.55M |
Net Income | -47.23M | 35.04M | 50.26M | -11.45M | 33.8M | -28.31M | -76.3M | 32.98M | 31.55M |
Selling & General & Admin | n/a | 3.18M | 2.72M | -1.97M | 2.87M | 1.44M | 1.56K | 1.65K | 1.56K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | 40.39M | n/a | -47.35M | n/a | n/a | n/a |
Operating Expenses | n/a | 3.18M | 2.72M | 38.42M | 2.87M | 14.95M | 38.87K | 15.9K | 15.22K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 16.49K | 8.11K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 65.43M | 3.18M | 2.72M | 41.01M | 2.87M | 50M | 86.47M | -16.99M | -2.52M |
Income Tax Expense | n/a | n/a | n/a | -43.81K | n/a | n/a | -843.92 | -1.06K | -1.01K |
Shares Outstanding (Basic) | 28.87M | 28.77M | 27.35M | 26.79M | 26.21M | 25.68M | 25.14M | 24.67M | 24.28M |
Shares Outstanding (Diluted) | 28.87M | 28.77M | 27.35M | 26.79M | 26.21M | 25.68M | 25.14M | 24.67M | 24.28M |
EPS (Basic) | -1.64 | 1.22 | 1.84 | -0.43 | 1.29 | -1.1 | -3.03 | 1.34 | 1.30 |
EPS (Diluted) | -1.64 | 1.22 | 1.84 | -0.43 | 1.29 | -1.1 | -3.03 | 1.34 | 1.30 |
EBITDA | -47.23M | n/a | 100.51M | -11.45M | n/a | -28.31M | -76.3M | 32.97M | 31.56M |
EBIT | -47.23M | -1.27M | 100.51M | -11.45M | -940.75K | -28.31M | -76.3M | 32.97M | 31.56M |
Depreciation & Amortization | n/a | 1.27M | 653.33K | 43.81K | 940.75K | 651.14K | 843.92 | 1.06K | 1.01K |
Source: Financial Modeling Prep. Financial Sources.